why choose us

First received: August 31, 2022

Clinical Trial: EVD Drainage Data and Intracranial Pressure (ICP) Measurements

Study Status: Completed

Recruit Status: RECRUITING

Condition: Hydrocephalus

Study Type: INTERVENTIONAL


Official Title: The Correlation Between FlowSense Flow Rate Measurements and: EVD Drainage Data and Intracranial Pressure (ICP) Measurements

Brief Summary: Rhaeos, Inc. is initially targeting hydrocephalus, a life threatening condition caused by an abnormal accumulation of cerebrospinal fluid (CSF).Implantable shunts, the gold standard treatment, often fail, leading to multiple trips to the emergency room and repeat surgeries.There is no technology available today that can easily assess CSF flow in shunts wirelessly, bedside, and without capital equipment until now.FlowSense, is a wireless, noninvasive thermal flow sensor that can be mounted on a patient's neck…

Read more